Evidence map›Paper›PMID 42237393›Full record

ArticleJournal of translational medicine2026

Unraveling the regulatory role of intercellular communication in intestinal immune cells mediated by H₂ in sepsis recovery through single-cell RNA sequencing.

Yanhua Luo, Yajuan Zhao, Jinfeng Liu, Bin Liu, Zhimei Zhang, Yuan Jiang, Yaopeng Zhang, Xue-Ting Wang, Shilong Li, Nian Zhao and 6 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yanhua Luo *Weifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Yajuan Zhao *Weifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Jinfeng Liu *Weifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Bin LiuWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Zhimei ZhangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Yuan JiangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Yaopeng ZhangSchool of Anesthesiology, Shandong Second Medical University, Weifang, Shandong, China.
Xue-Ting WangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Shilong LiWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Nian ZhaoWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Xiaokang LiWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Dong XiongWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China.
Xue ZhaoWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China. 19561419712@163.com.
Shaoqiang WangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China. wangshaoqiang227@163.com.
Weihang ZhangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China. 15169680287@163.com.
Bao LangWeifang People's Hospital, Shandong Second Medical University, 151 Guangwen Street, Weifang, Shandong, 261000, China. wfrmyy91@163.com.

Funding

2024 Annual Project of Medical and Health Sciences of Shandong Province/General Project 20241800073National Natural Science Foundation of China International (Regional) Cooperation and Exchange Project 32261160571Young Elite Sponsorship Program of Shandong Provincial Medical Association Young Elite Sponsorship Program of Shandong Provincial Medical Association
6 · The paper itself

Abstract

backgroundSepsis is a life-threatening condition with dysregulated immune responses, where the intestinal immune system plays a pivotal role. While hydrogen gas (H₂) has shown therapeutic potential, its precise impact on intestinal immune cell communication remains elusive.

methodsWe employed a murine model of sepsis induced by cecal ligation and puncture (CLP). Mice were divided into control, sepsis, and H₂-treated sepsis groups. A comprehensive approach combining single-cell RNA sequencing (scRNA-seq) of intestinal tissues with histological, biochemical, and functional analyses was used to dissect the immune landscape and H₂'s effects.

resultsH₂ treatment significantly ameliorated intestinal injury, reduced epithelial barrier leakage (evidenced by decreased serum DAO and FITC-dextran), and suppressed systemic inflammation. scRNA-seq revealed that H₂ restored sepsis-induced perturbations in both B and T cell subsets. It normalized the aberrant expansion of non-functional B cells and rectified T cell differentiation trajectories, promoting a functional balance. Mechanistically, H₂ modulated key genes (e.g., Stat3, Ccl5, Foxo1) and critical pathways including oxidative phosphorylation, B cell receptor signaling, and Foxo signaling. Furthermore, cell-cell communication analysis demonstrated that H₂ robustly enhanced the weakened interactions between T cells, B cells, and epithelial cells, particularly via the CCL signaling network.

conclusionOur study elucidates that H₂ therapy alleviates sepsis by systemically reprogramming the intestinal immune micro environment at the single-cell level. This is achieved by normalizing immune cell subsets, rewiring intercellular communication, and ultimately rebalancing the inflammatory response, positioning H₂ as a promising immunomodulatory agent for sepsis.

Indexed as

Cell CommunicationHydrogenIntestinesSepsisSequence Analysis, RNASingle-Cell AnalysisAnimalsB-LymphocytesGene Expression RegulationInflammationIntestinal Barrier FunctionIntestinal MucosaMaleMiceMice, Inbred C57BLSignal TransductionHydrogenB cellsCell-to-cell communicationH2 treatmentIntestinal immunitySepsisT cells

Identifiers

PMID42237393
PMCPMC13459925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.